BRD4 Inhibitor-32, identified by its CAS number 1445992-86-8, is a small molecule compound that acts as an inhibitor of the bromodomain-containing protein 4 (BRD4). This protein is involved in the regulation of gene expression and is implicated in various cancers and inflammatory diseases. The compound is characterized by its ability to selectively bind to the bromodomains of BRD4, thereby disrupting its interaction with acetylated lysines on histones and non-histone proteins. This inhibition can lead to altered transcriptional regulation and has potential therapeutic implications in oncology and other diseases where BRD4 plays a critical role. In terms of its chemical properties, BRD4 Inhibitor-32 typically exhibits moderate to high solubility in organic solvents and may have specific functional groups that contribute to its binding affinity and selectivity. As with many small molecule inhibitors, its efficacy and safety profile would be evaluated through preclinical and clinical studies to determine its potential as a therapeutic agent.

BRD4 Inhibitor-32

1445992-86-8: BRD4 Inhibitor-32, identified by its CAS number 1445992-86-8, is a small molecule compound that acts as an inhibitor of the bromodomain-containing protein 4 (BRD4). This protein is involved in the regulation of gene expression and is implicated in various cancers and inflammatory diseases. The compound is characterized by its ability to selectively bind to the bromodomains of BRD4, thereby disrupting its interaction with acetylated lysines on histones and non-histone proteins. This inhibition can lead to altered transcriptional regulation and has potential therapeutic implications in oncology and other diseases where BRD4 plays a critical role. In terms of its chemical properties, BRD4 Inhibitor-32 typically exhibits moderate to high solubility in organic solvents and may have specific functional groups that contribute to its binding affinity and selectivity. As with many small molecule inhibitors, its efficacy and safety profile would be evaluated through preclinical and clinical studies to determine its potential as a therapeutic agent.

<p>BRD4 Inhibitor-32 (example 15), a BRD4 inhibitor, is applicable in research pertaining to both acute and chronic kidney disease [1].</p>

CAS 1445992-86-8

BRD4 Inhibitor-32

BRD4 Inhibitor-32

Ref: TM-T85910